Biohit Oyj - Managers' Transactions
Biohit Oyj - Managers' Transactions, March 1, 2017 at 4:35 pm local time (EET)
Person subject to the notification requirement |
Name: |
Interlab Oy |
Legal Person |
Position: |
Closely associated person |
|
Person discharging managerial responsibilities in issuer |
Name: |
Suovaniemi, Osmo |
Position: |
Member of the Board/Deputy member |
|
|
|
|
Initial Notification |
|
Reference number: |
74370089ATTSNBXJVT29_20170301161015_1 |
|
|
|
Issuer |
Name: |
Biohit Oyj |
LEI: |
74370089ATTSNBXJVT29 |
|
|
|
Transaction details |
Transaction date: |
2017-02-22 |
Venue: |
NASDAQ HELSINKI LTD (XHEL) |
Nature of the transaction: |
Lending |
Further details: |
|
|
Linked to stock option programme |
|
Instrument: |
Share |
ISIN: |
FI0009005482 |
|
Volume: |
130000 |
Unit price: |
0,00000 Not Applicable |
|
Aggregated transactions |
Volume: |
130000 |
Volume weighted average price: |
0.00000 Not Applicable |
Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com
|